Gemmer Asset Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Gemmer Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$27.79 - $50.61 $2,640 - $4,807	-95 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$39.62 - $69.97 $3,090 - $5,457	-78 Reduced 45.09%	95 $4,000
Q4 2021 Jan 21, 2022	BUY	$58.09 - $82.51 $4,531 - $6,435	78 Added 82.11%	173 $11,000
Q3 2021 Oct 19, 2021	SELL	$58.38 - $84.96 $4,320 - $6,287	-74 Reduced 43.79%	95 $6,000
Q2 2021 Jul 23, 2021	BUY	$62.15 - $90.32 $4,599 - $6,683	74 Added 77.89%	169 $14,000
Q3 2020 Oct 21, 2020	SELL	$33.21 - $51.27 $431 - $666	-13 Reduced 12.04%	95 $4,000
Q2 2020 Jul 31, 2020	BUY	$26.12 - $43.27 $1,828 - $3,028	70 Added 184.21%	108 $5,000
Q1 2020 May 01, 2020	SELL	$20.56 - $63.12 $1,007 - $3,092	-49 Reduced 56.32%	38 $1,000
Q2 2019 Jul 18, 2019	BUY	$17.43 - $28.82 $1,516 - $2,507	87 New	87 $2,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.